Invesco India Contra Fund: Moving Against The Herd
Oct 03, 2019

Author: Divya Grover

(Image source: photo created by jcomp - freepik.com)

Equities are usually driven by prevailing sentiments in the market. These sentiments may cause some fundamentally sound stocks to be inappropriately priced in the short run. Investors usually tend to avoid such stocks due to fear of losing out. However, in the long run some of these stocks may grow to reflect its true value and reward investors for their patience.

Contra funds seek to find opportunities in such stocks that are currently out of favour with potential to gain in the future. Invesco India Contra Fund is one such fund which looks to identify such hidden opportunities and bet against the herd.

Launched in April 2007, IICF has a corpus of Rs 3,992 crore, which makes it the largest fund in its category. The fund is managed by Mr Amit Ganatra (since August 2012) and Mr Taher Badshah (since January 2017).

Investment objective: Invesco India Contra Fund aims to generate capital appreciation by investing predominantly in equity and equity related instruments through contrarian investing.

Graph 1:  Growth of Rs 10,000, if invested in IICF 5 years ago

Had you invested Rs 10,000 in IICF five years back on October 01, 2014, it would have grown to Rs 18,200 as on October 01, 2019. This translates into compounded annualised growth rate of 12.72%. In comparison a simultaneous investment of Rs 10,000 in its benchmark S&P BSE 500 - TRI would now be worth Rs 15,363 (a CAGR 8.97%). As can be seen in the chart alongside, the fund has generated significant alpha over its benchmark in the last five years.

Graph 2:  IICF Year-on-Year Performance

The year-on-year performance comparison of IICF vis-à-vis its benchmark S&P BSE 500 - TRI shows that the fund outperformed the benchmark in 6 out of last 10 calendar years. The fund performed better than the benchmark in CY 2009, CY 2011 and CY 2014 to CY 2017. Its performance was nearly in line with the benchmark in CY 2013. However, in CY 2018 and in the current year the fund has registered negative returns and trailed the benchmark.

Table 1: IICF Performance vis-à-vis category peers

Scheme Name Corpus (Cr.) 1-year (%) 2-year (%) 3-year (%) 5-year (%) Std Dev Sharpe
Invesco India Contra Fund 3,992 0.02 12.89 16.00 19.58 14.58 0.09
Kotak India EQ Contra Fund 819 4.16 13.59 15.75 14.77 12.17 0.10
SBI Contra Fund 1,309 -8.85 3.05 7.20 11.13 15.09 -0.10
S&P BSE 500 - TRI 0.07 9.47 12.54 12.81 13.41 0.03
Returns are on a rolling basis and in %, calculated using Direct Plan - Growth option. Those depicted over 1-Yr are compounded annualised.
Data as on October 1, 2019
(Source: ACE MF)

*Please note, this table only represents the best performing funds based solely on past returns and is NOT a recommendation. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator for future returns. The percentage returns shown are only for indicative purposes.


The universe of contra funds is fairly small with just three funds in the category. IICF outperformed the benchmark in 2-year, 3-year and 5-year rolling period but trailed in the 1-year rolling period.

While IICF stood as the category topper on a 3-year and 5-year rolling return basis, it stood behind Kotak India EQ Contra Fund in 1-year and 2-year rolling periods. However, the fund fared far better than SBI Contra Fund during this period.

In terms of risk-return parameters, IICF registered higher volatility as compared to the benchmark and average category peers. Nevertheless, it has managed to deliver decent risk-adjusted returns for the investors.

Investment strategy of IICF

Being a contra fund, IICF is mandated to invest at least 65% of its assets in equity and equity related instruments following a contrarian investment strategy. IICF looks to find hidden opportunities backed by research and expertise. It aims to select mispriced and out of favour stocks of fundamentally sound companies that have potential to grow in the long-term, and stay invested until full potential is realized.

The fund follows bottom-up approach to select companies trading below fundamental value, companies in turnaround phase and growth companies available at attractive valuations.

It takes active overweight/underweight sector positions w.r.t. the benchmark, based on the top-down view and valuation opportunities. The fund invests across market capitalisation and sectors.

Graph 3: IICF Portfolio Allocation And Market Capitalisation Trend

IICF has the flexibility to invest across market capitalisation. The fund stays fully invested in equities with major exposure to large caps along with significant allocation in mid and small caps. The fund has reduced its exposure to large caps from around 75% a year ago to around 62% at present. Meanwhile, allocation towards mid-caps has been increased gradually from around 10% a year ago to around 23% at present. The average holding in small caps in the last one year is around 11%. Rest of the holdings is maintained in the form cash equivalents.


Graph 4:  IICF Top Portfolio Holdings

Kotak Standard Multi-cap Fund Top Portfolio Holdings Kotak Standard Multi-cap Fund Top Portfolio Holdings
Holding (in %) as on August 31, 2019
(Source: ACE MF)


​IICF held 48 stocks in its portfolio as on August 31, 2019 diversified across sectors. The top 10 stocks constitute 46.6% of the total holdings. HDFC Bank tops the list with an allocation of 8.4%, followed by ICICI Bank (7.5%), Infosys (5.7%), Larsen & Toubro (4.9%) and ITC (4.5%). Rest of the stocks in the top 10 holdings have an allocation of around 3-4% each.

In terms of sector wise holdings, the fund has highest exposure to Banking at 21.6%, with another 7% in Finance. Infotech (12.8%) has the next highest allocation in the portfolio while Engineering and Consumption follow behind with an allocation of around 7% each. Auto and ancillaries, Pharmaceuticals, Petroleum Products and Power are the other prominent sectors in the portfolio.

Top Contributors

Among the stocks in the portfolio, ICICI Bank contributed the most to the fund's return in the last one year with a weighted return of 1.1%. Infosys, Apollo Hospitals Enterprise, HDFC Bank and Gujarat State Petronet were the other top contributors to the portfolio gains.

The stocks that eroded portfolio gains the most were ITC, Mahindra & Mahindra, Exide Industries, Equitas Holdings, and NALCO.

Suitability of IICF

IICF remains fully invested in equities, with its portfolio diversified across sectors and market capitalisation. Being a contra fund the scheme takes opposing view than the general popular opinion. Hence the fund may at times underperform over shorter time period. It is suitable for investors having tolerance to volatility and high risk appetite with an investment horizon of 5 years or more.

The fund has performed well, especially during longer time frames and has delivered decent risk-adjusted returns for its investors.

Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.

Editor's note: The last few years have not been among the best for equity mutual funds. While most funds have underperformed or are struggling to match the returns of the benchmark, there are few funds that have the potential to constantly generate alpha for its investors. And we have recently identified five such high alpha generating funds, in our latest report 'The Alpha Funds Report 2019'. Do not miss our latest research finding. Get your access to this exclusive report, right here!

DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

  1. Money Simplified Services Private Limited;

  2. PersonalFN Insurance Services India Private Limited;

  3. Equitymaster Agora Research Private Limited;

  4. Common Sense Living Private Limited;

  5. Quantum Advisors Private Limited;

  6. Quantum Asset Management Company Private Limited;

  7. HelpYourNGO.com India Private Limited;

  8. HelpYourNGO Foundation;

  9. Natural Streets for Performing Arts Foundation;

  10. Primary Real Estate Advisors Private Limited;

  11. HYNGO India Private Limited;

  12. Rahul Goel;

  13. I V Subramaniam.

Disclosure with regard to ownership and material conflicts of interest
  1. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company;

  2. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company; except for one of the research analysts holding units of Invesco India Contra Fund.

  3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

  4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

Disclosure with regard to receipt of Compensation
 
  1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

  2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

  3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

  4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

  5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

General disclosure
  1. The Research Analyst has not served as an officer, director or employee of the subject Company.

  2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Subject Company means Mutual Fund Schemes

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021 Corp. Office: 16 Jolly Maker Chambers II, Nariman Point, Mumbai 400 021.

Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013



Add Comments